当前位置:首页 - 行情中心 - 联环药业(600513) - 财务分析

联环药业

(600513)

  

流通市值:26.01亿  总市值:26.01亿
流通股本:2.85亿   总股本:2.85亿

联环药业(600513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.27亿元,每股收益0.08元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益178588.45万元,未分配利润76824.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产362358.20万元,负债183769.75万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入627,705,511.572,160,457,160.631,644,578,576.251,126,339,878.99
营业总成本587,869,188.522,050,251,134.721,516,612,393.881,035,476,886.36
营业利润41,277,165.36131,019,022.27122,482,789.5487,252,305.63
利润总额41,458,668.98130,427,783.25121,979,496.6587,068,562.67
净利润27,393,898.07106,414,745.34107,539,004.5972,681,079.59
其他综合收益-93,937.2178,920.88-73,049.96-43,210.19
综合收益总额27,299,960.86106,493,666.22107,465,954.6372,637,869.4
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计1,738,435,699.241,478,067,504.751,384,873,898.481,336,824,219.56
非流动资产合计1,885,146,257.971,541,405,046.381,645,712,564.311,590,577,903.84
资产总计3,623,581,957.213,019,472,551.133,030,586,462.792,927,402,123.4
流动负债合计1,481,546,064.21,339,770,538.481,431,127,265.441,356,866,880.46
非流动负债合计356,151,428.21102,486,523.6321,271,419.9227,175,550.74
负债合计1,837,697,492.411,442,257,062.111,452,398,685.361,384,042,431.2
归属于母公司股东权益合计1,418,575,187.311,395,609,544.931,403,996,744.381,374,215,324.68
股东权益合计1,785,884,464.81,577,215,489.021,578,187,777.431,543,359,692.2
负债和股东权益合计3,623,581,957.213,019,472,551.133,030,586,462.792,927,402,123.4
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计656,872,880.312,341,878,198.171,816,743,541.61,282,702,295.84
经营活动现金流出小计709,968,744.242,331,112,426.011,792,699,438.631,310,160,134.66
经营活动产生的现金流量净额-53,095,863.9310,765,772.1624,044,102.97-27,457,838.82
投资活动现金流入小计2,86822,012,747.47700-
投资活动现金流出小计194,255,050.09206,845,345.89135,919,447.42116,044,532.69
投资活动产生的现金流量净额-194,252,182.09-184,832,598.42-135,918,747.42-116,044,532.69
筹资活动现金流入小计534,387,620.14852,979,092.69533,012,809.3349,400,000
筹资活动现金流出小计231,799,957.64743,037,128.67480,020,125.74325,733,378.1
筹资活动产生的现金流量净额302,587,662.5109,941,964.0252,992,683.5623,666,621.9
汇率变动对现金及现金等价物的影响199,397.61628,724.91103,516.6619,062.24
现金及现金等价物净增加额55,439,014.09-63,496,137.33-58,778,444.23-119,816,687.37
期末现金及现金等价物余额242,132,899.33186,693,885.24191,411,578.34130,373,335.2
TOP↑